Acta Cancerológica     2003; 32 (1):3-4

 

TUMORES ESTROMALES GASTROINTESTINALES (GIST)

 

BIBLIOGRAFÍA

  1. Kindblom LG, Remotti HE, Aldenberg F, Meis-Kindb1om JM. Gastrointestinal pacemaker cell tumors (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Path 1998; 152:1259-1269.

  2. Stemberg SS, Antonioli DA, Carter D, Mills SE and Oberman HA, Diagnostic surgical pathology. 3rd edition 1999; Vol 2:pp 1337 - 1339 & 1454-1457.

  3. Mazur MT, Clark HB: Gastric Stromal Tumors. Deppraisal of Histogenesis. Am J. Surg Pathol 1983; 7: 507-519.

  4. Rosai J. Ackerman's surgical pathology. 8th edition 1996; Vol 1: pp 1645-647

  5. Lewin KD, Appleman HD. Tumors of the esophagus and stomach. Atlas of tumor pathology, 3rd. Series, Fascicle 8. Washington D.C.: AFIP 1996. pp 405-435

  6. Hillemanns M. Pasold S. Bottcher K. Hofler H. Pronostic factors of gastrointestinal stromal tumors of the stomach. Verh Disch Ges Pathol 1998:
    82:261 - 6.

  7. Yoo J, Lee HK, Kang CS, Park WA, Lee JY. Shim SI. P 53 gene mutations and p 53 protein expression in human soft tissue sarcoma. Arch Pathol Lab Med 1997; 121:395-9.

  8. Rubin BP, Fletcher JA, Fletcher Cd Molecular insights into the histogenesis and pathologenesis of gastrointestinal stromal tumors. Int J Surg pathol 2000;8:5-10.

  9. Xiaojuan W.etal . Hospful parameters for Malignant Potential of Gastrointestinal Stromal Tumors (GIST). Jpn J. Clin Oncol 2002; 32 (9) 47-351.

  10. El Rifai W, Sarcomo RM, Andersson LC, Mieffinem M, Knuntia S. DNA copy number changes in gastrointestinal stromal tumors - a distinct genetic entity. Amm chir Gynalcol 1998, 87: 287-290.

  11. El Rifai W, Sarlomo Rm, Miettinem M, Knucetia S, Andersson LC. DNA copy number losses inchrosmoseme 14: and early change in gastrointestinal stromal tumors. 1993 Cancer Res 56: 3230-3233.

  12. Hirota S, Isozaki K. Moriyama Y. Hashimoto K, Nishita T. Ishiguro S, et al. Gain - of- function mutations of c- kit in human gastrointestinal stromal tumors. Science 1998;279: 577-80.

  13. Tazawa K. Tsukada K. Makuuchi H. Tsutsumi Y. An immunohistochemical and clinicopathological study of gastrointestinal stromal tumors. Pathol int 1999; 49: 786 - 98.

  14. Wang X-J, Tang W-H, Yu P-L. Su X - P, Li S- Y, Histological and immunohistochemical study and AgNOR analysis of smooth muscle tumors of the digestive tract. Zhong Hua Zhong Liu Za Zhi 1994;3 (16): 128 - 31.

  15. Chang MS, Choe G, Kim WH, Kim YI. Small intestinal stromal tumors: a clinicophatology study of 31 tumos. Pathol Int 1998; 48: 341 - 7.

  16. Emory TS. Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors. An J Surg Pathol 1999;23:82 - 7.

  17. Miettinen M, Sarlomo - Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their bioloby. Um Pathol 1999;30:1213 - 20.

  18. Amin MB, Ma CK, Linden MD, Kubus JJ, Zarbo RJ. Prognostic value of proliferating el nuclearantigen index in gastric stromal tumors. Am J Clinic Phatol 1993; 100:428 - 32.

  19. Demarchi LM. Reis MM, Palomino SA, Garhat C. Takagaki TY, Beyruti R, et al. Prononostic values of stromal proportion and PCNA, Ki -67 and p 53 proteins in patients with resected adenocarcinoma of the lung. Mod Pathol 2000; 13:511-20.

  20. Van de Rijn M, Hendrickson MR, Rouse RV: The CD34 expression in by gastrointestinal stromal Hum Path 1994;25: 766 - 771.

Regresar


back.gif (71 bytes) Contenido

Volumenes anteriores